ASCEND BY NTHRYS
Research Abroad Products

Exomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 121–132 of 200 project topics
Cardiac Risk Stratification Engine SaaS Platform
A cloud-based analytics platform that processes exomic biomarkers to predict cardiovascular disease risk and patient outcomes in real-time. Delivers recurring revenue through subscription licensing to hospitals, insurers, and diagnostic labs seeking precision risk assessment.
Cardiovascular Exomics Analytics Platform Click to view more details →
Exosomal Biomarker Detection and Sequencing Service
A laboratory-as-a-service offering that isolates, analyzes, and reports cardiac exosomal biomarkers for clinical and commercial clients. Generates revenue through per-sample testing fees, volume contracts, and clinical trial partnerships.
Cardiovascular Exomics Analytics Platform Click to view more details →
Real-Time Heart Failure Monitoring Analytics Dashboard
An integrated software platform that continuously tracks exomic signatures in heart failure patients and alerts clinicians to disease progression. Monetizes through subscription tiers, integration partnerships with EHR vendors, and remote monitoring service fees.
Cardiovascular Exomics Analytics Platform Click to view more details →
Atherosclerosis Progression Prediction Commercial Tool
A proprietary algorithmic tool that uses exomic data to forecast atherosclerotic plaque development and rupture risk in patient cohorts. Creates value through licensing to pharmaceutical companies, medical device manufacturers, and cardiovascular clinics for patient selection and intervention timing.
Cardiovascular Exomics Analytics Platform Click to view more details →
Personalized Cardiac Drug Response Prediction Platform
A precision medicine SaaS that leverages exomic biomarkers to predict medication efficacy and adverse events for cardiovascular therapies. Drives revenue through pharma partnerships, pharmacogenomics licensing agreements, and per-patient precision dosing recommendations.
Cardiovascular Exomics Analytics Platform Click to view more details →
Myocardial Infarction Risk Intelligence Commercial API
A RESTful API service that integrates exomic analytics to deliver real-time MI risk scores to healthcare provider networks and health systems. Monetizes through API call pricing, enterprise licensing, and integration fees from EHR and patient engagement platforms.
Cardiovascular Exomics Analytics Platform Click to view more details →
Arrhythmia Phenotyping and Outcome Prediction Software
A commercial software suite that classifies arrhythmia subtypes using exomic profiles and predicts treatment response and mortality risk. Generates revenue through software licensing, clinical laboratory integration partnerships, and electrophysiology center subscriptions.
Cardiovascular Exomics Analytics Platform Click to view more details →
Cardiovascular Biomarker Discovery and Validation Service
A contract research service that identifies, validates, and de-risks novel exomic biomarkers for cardiac disease detection and stratification. Delivers value through sponsored research agreements with biotech firms, diagnostic companies, and institutional clients seeking biomarker assets.
Cardiovascular Exomics Analytics Platform Click to view more details →
Transplant Recipient Cardiac Outcome Prediction Tool
A specialized analytics platform that uses exomic data to predict post-transplant cardiac complications and graft survival outcomes. Monetizes through licensing to transplant centers, organ procurement organizations, and health systems managing cardiac transplant programs.
Cardiovascular Exomics Analytics Platform Click to view more details →
Inflammation-Driven Cardiovascular Risk Scoring Engine
A cloud-analytics engine that quantifies inflammation-related exomic signatures to calculate and track cardiovascular risk trajectories in patient populations. Delivers commercial value through insurance risk model integration, population health contracts, and preventive care program subscriptions.
Cardiovascular Exomics Analytics Platform Click to view more details →
AI-Powered Exosome Biomarker Screening SaaS Platform
A cloud-based software platform that uses machine learning algorithms to identify and validate novel exosome biomarkers from multi-omics datasets in real-time. Enables diagnostic companies and research institutions to reduce biomarker discovery timelines by 60% while licensing validated biomarker panels to pharma partners for recurring revenue.
Exosome Biomarker Discovery Platform Dev Click to view more details →
Multiplexed Exosome Protein Detection Assay Kit
A commercial immunoassay kit enabling simultaneous detection of 50+ exosomal protein biomarkers in blood, urine, and CSF samples with single-test workflow. Generates high-margin consumable sales and establishes customers'' dependency on proprietary reagent supply through exclusive partnerships with clinical laboratories and diagnostic centers.
Exosome Biomarker Discovery Platform Dev Click to view more details →